These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8734083)

  • 1. [Association of dysfibrinogenemia and thrombosis. Apropos of a family (Fibrinogen Melun) and review of the literature].
    Bentolila S; Samama MM; Conard J; Horellou MH; Ffrench P
    Ann Med Interne (Paris); 1995; 146(8):575-80. PubMed ID: 8734083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
    Haverkate F; Samama M
    Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Bbeta14 Arg-->Cys: further evidence for a role in thrombosis.
    Vakalopoulou S; Mille-Baker B; Mumford A; Manning R; Laffan M
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):403-8. PubMed ID: 10695765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of congenital dysfibrinogenemia associated with thrombosis - Fibrinogen Praha III and Fibrinogen Plzen.
    Kotlín R; Reicheltová Z; Malý M; Suttnar J; Sobotková A; Salaj P; Hirmerová J; Riedel T; Dyr JE
    Thromb Haemost; 2009 Sep; 102(3):479-86. PubMed ID: 19718467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexisting dysfibrinogenemia (gammaR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids).
    Siebenlist KR; Mosesson MW; Meh DA; DiOrio JP; Albrecht RM; Olson JD
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):293-304. PubMed ID: 10870810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
    Miesbach W; Galanakis D; Scharrer I
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
    Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects.
    Miesbach W; Scharrer I; Henschen A; Neerman-Arbez M; Spitzer S; Galanakis D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):35-40. PubMed ID: 19923982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in exon 2 of FGB caused by c.221G>T
    Shlebak AA; Katsarou AD; Adams G; Fernando F
    J Thromb Thrombolysis; 2017 Feb; 43(2):263-270. PubMed ID: 27812779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance.
    Flood VH; Al-Mondhiry HA; Farrell DH
    Br J Haematol; 2006 Jul; 134(2):220-6. PubMed ID: 16846481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial infarction and thromboembolism during pregnancy].
    Härtel D; Sorges E; Carlsson J; Römer V; Tebbe U
    Herz; 2003 May; 28(3):175-84. PubMed ID: 12756475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary dysfibrinogenaemia. Study of a family (author's transl)].
    Voinnesson A; Salaün M
    Sem Hop; 1979 Oct 8-15; 55(33-34):1507-12. PubMed ID: 229560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis.
    Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism: implications for gene-based diagnosis and technology development.
    Hooper WC; De Staercke C
    Expert Rev Mol Diagn; 2002 Nov; 2(6):576-86. PubMed ID: 12465454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.